BR112013002230A2 - marcadores de peso molecular de acetato de glatiramer - Google Patents

marcadores de peso molecular de acetato de glatiramer

Info

Publication number
BR112013002230A2
BR112013002230A2 BR112013002230A BR112013002230A BR112013002230A2 BR 112013002230 A2 BR112013002230 A2 BR 112013002230A2 BR 112013002230 A BR112013002230 A BR 112013002230A BR 112013002230 A BR112013002230 A BR 112013002230A BR 112013002230 A2 BR112013002230 A2 BR 112013002230A2
Authority
BR
Brazil
Prior art keywords
molecular weight
glatiramer acetate
weight markers
acetate molecular
markers
Prior art date
Application number
BR112013002230A
Other languages
English (en)
Inventor
Bala Harsha Vardhan Ganji
Basanthi Devi
Chakravarthula Kalyan Narasimham Nallam
Karthik Ramasamy
Ravindra Chary Barhoju
Santhanakrishnan Srinivasan
Sudheer Reddy Kallam
Yagna Kiran Kumar Komaravolu
Original Assignee
Reddys Lab Inc Dr
Reddys Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Inc Dr, Reddys Lab Ltd Dr filed Critical Reddys Lab Inc Dr
Publication of BR112013002230A2 publication Critical patent/BR112013002230A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size selective separation, e.g. size exclusion chromatography, gel filtration, permeation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

marcadores de peso molecular de acetato de glatiramer. aspectos do presente pedido de patente referem-se aos marcadores de peso molecular de acetato de glatiramer para a determinação exata do peso molecular médio do acetato de glatiramer.
BR112013002230A 2010-07-29 2011-07-28 marcadores de peso molecular de acetato de glatiramer BR112013002230A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2146CH2010 2010-07-29
US38936010P 2010-10-04 2010-10-04
PCT/US2011/045724 WO2012016042A2 (en) 2010-07-29 2011-07-28 Glatiramer acetate molecular weight markers

Publications (1)

Publication Number Publication Date
BR112013002230A2 true BR112013002230A2 (pt) 2016-05-24

Family

ID=45530721

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013002230A BR112013002230A2 (pt) 2010-07-29 2011-07-28 marcadores de peso molecular de acetato de glatiramer

Country Status (13)

Country Link
US (1) US9109006B2 (pt)
EP (1) EP2598889A4 (pt)
JP (1) JP2013535474A (pt)
KR (1) KR20130043196A (pt)
CN (1) CN103080747B (pt)
AU (1) AU2011282635B2 (pt)
BR (1) BR112013002230A2 (pt)
CA (1) CA2806997A1 (pt)
MX (1) MX2013001150A (pt)
NZ (1) NZ606723A (pt)
RU (1) RU2013108828A (pt)
WO (1) WO2012016042A2 (pt)
ZA (1) ZA201300980B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012123959A2 (en) 2011-02-14 2012-09-20 Usv Limited Copolymer-1, process for preparation and analytical methods thereof
CN104098655B (zh) * 2013-04-09 2018-01-30 深圳翰宇药业股份有限公司 用于合成醋酸格拉替雷的质谱内标的多肽
CN112649537B (zh) * 2015-04-28 2024-03-29 深圳翰宇药业股份有限公司 多肽混合物高效液相色谱分析方法
EP3147667B1 (en) * 2015-09-24 2019-06-12 CHEMI S.p.A. Analysis of the molecular weight distribution of complex polypeptide mixtures
US12097292B2 (en) 2016-08-28 2024-09-24 Mapi Pharma Ltd. Process for preparing microparticles containing glatiramer acetate
US11167003B2 (en) 2017-03-26 2021-11-09 Mapi Pharma Ltd. Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems
KR102438261B1 (ko) * 2017-12-14 2022-08-30 엘지디스플레이 주식회사 디스플레이 장치
JP7273996B2 (ja) * 2019-12-20 2023-05-15 株式会社日立ハイテク 電気泳動用分子量マーカー、核酸分画方法及び核酸のサイズ分析方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800808A (en) * 1994-05-24 1998-09-01 Veda Research And Development Co., Ltd. Copolymer-1 improvements in compositions of copolymers
US6514938B1 (en) * 1998-09-25 2003-02-04 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
US6800287B2 (en) * 1998-09-25 2004-10-05 Yeda Research And Development Co., Ltd. Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
US20030157720A1 (en) * 2002-02-06 2003-08-21 Expression Technologies Inc. Protein standard for estimating size and mass
HUE028833T2 (en) * 2004-09-09 2017-01-30 Yeda Res & Dev Polypeptide mixtures, compositions containing them, process for their preparation, and applications
JP5297653B2 (ja) * 2004-10-29 2013-09-25 サンド・アクチエンゲゼルシヤフト グラチラマーの製造法
CN101111252A (zh) * 2005-02-02 2008-01-23 泰华制药工业有限公司 一种通过氢解反应生产多肽混合物的方法
US20070059798A1 (en) 2005-09-09 2007-03-15 Alexander Gad Polypeptides useful for molecular weight determinations
US20090111133A1 (en) 2007-10-31 2009-04-30 Abbott Laboratories Gel Filtration Standard
US20100285593A1 (en) 2007-11-26 2010-11-11 Waters Technologies Corporation Internal standards and methods for use in quantitatively measuring analytes in a sample
CA2797227A1 (en) * 2010-04-27 2011-11-10 Dr. Reddy's Laboratories Ltd. Preparation of polypeptides and salts thereof
WO2012123959A2 (en) * 2011-02-14 2012-09-20 Usv Limited Copolymer-1, process for preparation and analytical methods thereof

Also Published As

Publication number Publication date
JP2013535474A (ja) 2013-09-12
CN103080747A (zh) 2013-05-01
US9109006B2 (en) 2015-08-18
KR20130043196A (ko) 2013-04-29
CN103080747B (zh) 2016-04-27
ZA201300980B (en) 2014-03-26
NZ606723A (en) 2015-11-27
CA2806997A1 (en) 2012-02-02
AU2011282635A1 (en) 2013-02-28
EP2598889A2 (en) 2013-06-05
AU2011282635B2 (en) 2015-05-28
MX2013001150A (es) 2013-05-30
EP2598889A4 (en) 2014-01-22
RU2013108828A (ru) 2014-09-10
US20130205877A1 (en) 2013-08-15
WO2012016042A3 (en) 2012-05-31
WO2012016042A2 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
BR112013002230A2 (pt) marcadores de peso molecular de acetato de glatiramer
CR20140132A (es) Derivados de pirrolopirimidina y purina
CY1119245T1 (el) Φαρμακευτικη συνθεση καρβετοκινης
CO6801646A2 (es) Eliminación de células diana por parte de células t citotóxicas específicas de virus utilizando complejos que comprenden mhc de clase i
BR112014027925A2 (pt) recipientes flexíveis
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
CR20130419A (es) Derivados heterocíclicos de amina
BR112014013108A2 (pt) compostos tricíclicos fundidos como inibidores da quinase raf
CR20130539A (es) Triazolopiridinas
CR20120513A (es) HETEROARIL-CICLOHEXIL-TETRAAZABENZO [e] AZULENOS
BR112013025845A2 (pt) formulações com viscosidade reduzida
BR112013025866A2 (pt) formulações com viscosidade reduzida
DK2718363T3 (da) Vandig flydepunktnedsættende additivsammensætning
CO6821935A2 (es) Derivados novedosos de cefalosporinas y cmposiciones farmacéuticas de estos
BR112014025041B8 (pt) Composição farmacêutica
BR112013032555A2 (pt) composição selante híbrida
BR112014018738A8 (pt) Métodos e intermediários para preparo de agentes farmacêuticos
CL2013003201A1 (es) Composiciones rociables para reducir particulados en el aire que comprende un polimero zwitterionico de formula i.
DK2561890T3 (da) Fremgangsmåde til fremstilling af medikamenter til bekæmpelse af tumorer
GT201300003A (es) Forma cristalina delta de la sal de arginina de perindoprilo, su procedimiento de preparacion , y las composiciones farmacèuticas que la contienen
CY1117170T1 (el) Συνθεση ολιγοσακχαριτων για προληψη ή μειωση του κινδυνου μεταβολικου συνδρομου
BR112013029905A2 (pt) composições lubrificante com polímeros funcionalizados com fosfato
CR20140531A (es) Derivados de ariletinilo
BR112013007603A2 (pt) composição de acelerador para elastômeros
BR112014011723A2 (pt) composição antiperspirante

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]